Axolot Solutions (AXOLOT) Q1 2025 earnings summary

Executive summary

• Achieved breakthrough for AxoPur in PFAS purification, with a major contract in the Mälar region and first strategic order in Chile.

• Strategic shift to partner-driven market expansion, notably with Mellifiq, leading to increased order flow and reduced operational risk.

• Focused on international growth, prioritizing markets with strong environmental regulation and water scarcity.

Financial highlights

• Net sales reached 2,480 tkr in Q1 2025, up from 908 tkr (internal) in Q1 2024, driven by reactor and system sales plus royalties.

• Operating result was -1,417 tkr (Q1 2024: -664 tkr); net result -1,500 tkr (Q1 2024: -3,614 tkr).

• Cash flow from operations and investments was -1,976 tkr; cash at period end was 5,306 tkr (start of year: 7,282 tkr).

• Royalty revenues in Q1 2025 totaled 915 tkr.

• Equity at period end was 71,183 tkr (Q1 2024: 65,712 tkr).

Outlook and guidance

• Continued focus on expanding through partnerships, with 2025 targets to establish 2–3 new market partnerships.

• Priority on Chile and South America for new collaborations and orders.

• Anticipates increased demand for PFAS purification due to regulatory and legal developments.